AEGiS-Reuters: Bristol-Myers says once-day Videx approved in EU

Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Bristol-Myers says once-day Videx approved in EU

Reuters NewMedia - Thursday June 3, 1999

LONDON, June 3 (Reuters) - U.S. drugs group Bristol-Myers Squibb Co (NYSE:BMY - news) said on Thursday a once-a-day version of its AIDS/HIV treatment Videx had been approved for sale across the European Union.

In a statement, Bristol-Myers said the new version of the drug would make life easier for people taking the cocktails of pills which are crucial in fighting the disease.

Videx is a nucleoside reverse transcriptase inhibitor, a class of drug which forms the foundation of combination therapy. Previous versions of the drug have been on the market for almost seven years.
990603
RE990606

Copyright © 1999 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .